Company / Revenue per Share
Doximity Revenue per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.94
FY2024
5-year range
$1.80 / $5.05
FY2020-FY2024
Trend
+19.0%
vs FY2023
Sector context
#136 of 147
Health Care
What the data says
Among 147 Health Care companies, Doximity is in the bottom 7% for revenue per share. Revenue per Share has fluctuated over the past 6 years, ranging from $1.42 in FY2019 to $5.05 in FY2022.
Based on SEC 10-K filings.
2.94 in FY2024 with a 5-year CAGR of +15.6%.
Declined from $5.05 to $2.94 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +17.8%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 147This company $2.94 Sector average $127.83
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2024, revenue per share increased 19.0% year-over-year.
- Ranks #136 out of 147 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $2.94 | +19.0% |
| FY2023 | $2.47 | -51.1% |
| FY2022 | $5.05 | +181.0% |
| FY2021 | $1.80 | -17.3% |
| FY2020 | $2.17 | +52.7% |
| FY2019 | $1.42 | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026